Skip to main content

Table 1 IC50 values of C212 and curcumin in cancer cell lines (48-h treatment; Cur, curcumin)

From: Curcumin derivative C212 inhibits Hsp90 and eliminates both growing and quiescent leukemia cells in deep dormancy

  

HL-60

K562

HCT116

SW620

HT29

MCF-7

SGC7901

HepG2

Growth% under C212 vs. Cur (p-value)

0.8 μM

1.6E-01

9.7E-03

3.3E-02

9.4E-03

 

2.8E-02

 

3.5E-02

1.6 μM

1.1E-03

7.4E-03

3.5E-02

5.6E-04

4.8E-01

4.7E-02

1.7E-01

4.9E-03

3.2 μM

2.3E-07

2.7E-03

1.2E-02

3.3E-04

6.0E-02

2.2E-01

3.2E-01

3.2E-03

6.3 μM

7.0E-05

4.3E-04

1.5E-03

8.1E-04

4.6E-03

4.0E-04

1.3E-03

5.4E-03

12.5 μM

1.2E-03

7.1E-03

3.6E-05

9.5E-03

4.6E-01

1.3E-04

7.3E-04

6.2E-03

IC 50 (μM)

C212

1.2

3.7

3.4

1.9

8.2

6.3

6.7

3.4

Cur

17.6

14.8

11.0

7.1

10.0

12.6

18.9

12.3

C212/Cur

0.07

0.25

0.31

0.27

0.82

0.50

0.36

0.27

Mean (IC50 C212/Cur)

0.16

0.47

0.50

0.36

0.27

AUC

C212

108.1

140.4

145.2

122.1

173.5

164.0

174.7

140.5

Cur

155.5

174.6

173.2

162.9

180.0

179.7

183.4

175.9

C212/Cur

0.70

0.80

0.84

0.75

0.96

0.91

0.95

0.80

Mean (AUC C212/Cur)

0.75

0.85

0.91

0.95

0.80